Parkinson's Disease: Biomarkers

Parkinson’s disease is a progressive neurodegenerative disorder that affects movement. This feed focuses on genomic and drug-response biomarkers in Parkinson’s disease.

May 2, 2018

Genetic characterization of Vitis germplasm collected from the southwestern US and Mexico to expedite Pierce's disease-resistance breeding

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
S RiazM A Walker
January 18, 2018
Review

Rheumatoid arthritis and periodontal disease: What are the similarities and differences?

International Journal of Rheumatic Diseases
Rongbin LiJianwei Li
January 7, 2019
Preprint
Open Access

Therapeutic potential of inhibition of the neuroinflammation induced cathepsin X: in vivo evidence

BioRxiv : the Preprint Server for Biology
Anja PišlarJanko Kos
May 17, 2019
Preprint
Open Access

The Emerging Gait Dysfunction Phenotype in Idiopathic Parkinson’s Disease

BioRxiv : the Preprint Server for Biology
Frank M. SkidmoreElizabeth A Disbrow
August 14, 2019
Open Access

The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes

International Journal of Molecular Sciences
Miriam CianiLuisa Benussi
January 11, 2019
Open Access

Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases

Neurobiology of Learning and Memory
Katharine J Liang, Erik S Carlson
February 1, 2019
Open Access

Depression symptomatology correlates with event-related potentials in Parkinson's disease: An affective priming study

Journal of Affective Disorders
Nadeeka N W DissanayakaDavid A Copland
February 10, 2018
Open Access

Prioritizing disease genes with an improved dual label propagation framework

BMC Bioinformatics
Yaogong ZhangMaoQiang Xie
January 18, 2019

EEG Resting-State Networks in Dementia with Lewy Bodies Associated with Clinical Symptoms

Neuropsychobiology
Yasunori AokiManabu Ikeda
July 23, 2019
Open Access

Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Anto P RajkumarDag Aarsland
March 17, 2020
Open Access

Brain insulin resistance: role in neurodegenerative disease and potential for targeting

Expert Opinion on Investigational Drugs
Christian Hölscher
March 3, 2020
Open Access

Genetic Burden for Late-Life Neurodegenerative Disease and Its Association With Early-Life Lipids, Brain, Behavior, and Cognition

Frontiers in Psychiatry
Sander LamballaisHieab H H Adams
August 22, 2019
Case Report
Open Access

Eye-of-the-tiger Sign in Neurodegeneration with Brain Iron Accumulation

Curēus
Madeline GoldbergAunali S Khaku
July 1, 2018
Review

Short-afferent inhibition and cognitive impairment in Parkinson's disease: A quantitative review and challenges

Neuroscience Letters
Juan Francisco Martin-Rodriguez, Pablo Mir

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS - Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementias present as cognitive decline that is not a part of normal aging. Age-related dementias include Alzheimer's disease, vascular dementia, and Lewy body dementia. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-biomarkers/28ca42d2-e7b5-4c4f-9932-3384c44e101f